ArticleMedical oncology (Northwood, London, England)2025

Overexpression of miR-29a and miR-29b is involved in imatinib resistance via abrogated NF1 expression and increased ERK1/2 activation in chronic myeloid leukemia cells.

Masanobu Tsubaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.